BEOVU

Google image searchProduct monograph

Active ingredient

brolucizumab, 6 MG/0.05 ML

DIN: 02496976

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVITREAL

Description: SINGLE USE PRE-FILLED SYRINGE

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 15-MAY-2020

ATC:

• S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
• S01L — OCULAR VASCULAR DISORDER AGENTS (ATC, ATC/DDD)
• S01LA — Antineovascularisation agents (ATC, ATC/DDD)
• S01LA06 — BROLUCIZUMAB (ATC/DDD)

External Links for Beovu

Search on Google

• Beovu side effects
• Beovu dosage
• brolucizumab side effects
• brolucizumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find beovu photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.